Waters Corporation
Price data unavailable
Track WAT in your trading journalAbout Waters Corporation
Waters Corporation (Nasdaq/NYSE: WAT) is a Life Sciences Tools & Services company operating within the Health Care sector of the US equity market.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
The company reports trailing twelve-month revenue of $1.27B and net loss of $72.00M.
Key metrics include a return on equity of -0.5%, a debt-to-equity ratio of 0.60.
Use FINOTAUR to track WAT's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $1.27B |
| Net Income (TTM) | $-72.00M |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | -0.47% |
| Debt-to-Equity | 0.60 |
| Dividend per Share | — |
Recent News
Want real-time analysis on WAT?
Track it free in your trading journal. Log trades, tag setups, and review your edge.